Kitov Pharmaceuticals Holdings PE Ratio 2014-2018 | KTOV

Current and historical p/e ratio for Kitov Pharmaceuticals Holdings (KTOV) from 2014 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Kitov Pharmaceuticals Holdings PE ratio as of June 24, 2019 is 0.00.
Kitov Pharmaceuticals Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-06-25 0.94 inf
2018-12-31 0.66 0 0.00
2018-06-30 2.64 0 0.00
2017-12-31 2.28 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.014B $0.001B
Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.313B 34.70
Takeda Pharmaceutical (TAK) Japan $27.201B 7.99
Grifols (GRFS) Spain $13.779B 17.43
Sage Therapeutics (SAGE) United States $9.044B 0.00
Ionis Pharmaceuticals (IONS) United States $8.958B 19.58
Neurocrine Biosciences (NBIX) United States $7.714B 0.00
Catalent (CTLT) United States $7.679B 30.82
Jazz Pharmaceuticals (JAZZ) Ireland $7.437B 10.19
Nektar Therapeutics (NKTR) United States $5.907B 9.63
Tilray (TLRY) Canada $4.670B 0.00
FibroGen (FGEN) United States $3.751B 0.00
United Therapeutics (UTHR) United States $3.332B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.309B 11.61
Arrowhead Pharmaceuticals (ARWR) United States $2.607B 392.86
PTC Therapeutics (PTCT) United States $2.470B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.924B 6.92
Xencor (XNCR) United States $1.909B 52.11
Portola Pharmaceuticals (PTLA) United States $1.796B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.781B 86.24
Zogenix (ZGNX) United States $1.730B 0.00
Tricida (TCDA) United States $1.720B 0.00
USANA Health Sciences (USNA) United States $1.688B 14.67
Enanta Pharmaceuticals (ENTA) United States $1.630B 22.28
Ironwood Pharmaceuticals (IRWD) United States $1.590B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.557B 0.00
Heron Therapeutics (HRTX) United States $1.406B 0.00
Aerie Pharmaceuticals (AERI) United States $1.387B 0.00
Turning Point Therapeutics (TPTX) United States $1.322B 0.00
Esperion Therapeutics (ESPR) United States $1.309B 0.00
Corcept Therapeutics (CORT) United States $1.190B 16.98
ArQule (ARQL) United States $1.094B 0.00
Radius Health (RDUS) United States $1.078B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.916B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.899B 0.00
Endo (ENDP) Ireland $0.812B 1.31
Aptorum Group (APM) China $0.755B 0.00
Odonate Therapeutics (ODT) United States $0.751B 0.00
CannTrust Holdings (CTST) Canada $0.706B 0.00
Organogenesis Holdings (ORGO) United States $0.658B 0.00
Translate Bio (TBIO) United States $0.638B 0.00
TherapeuticsMD (TXMD) United States $0.603B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.567B 0.00
Dermira (DERM) United States $0.510B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
ChemoCentryx (CCXI) United States $0.495B 0.00
GlycoMimetics (GLYC) United States $0.485B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Siga Technologies (SIGA) United States $0.450B 1.06
BioSpecifics Technologies Corp (BSTC) United States $0.420B 21.18
Flexion Therapeutics (FLXN) United States $0.414B 0.00
Collegium Pharmaceutical (COLL) United States $0.414B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.400B 0.00
Karyopharm Therapeutics (KPTI) United States $0.386B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.371B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.370B 0.00
KalVista Pharmaceuticals (KALV) United States $0.367B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.349B 0.00
TCR2 Therapeutics (TCRR) United States $0.349B 0.00
Rafael Holdings (RFL) United States $0.334B 0.00
Forty Seven (FTSV) United States $0.333B 0.00
Harpoon Therapeutics (HARP) United States $0.309B 0.00
Molecular Templates (MTEM) United States $0.299B 0.00
OptiNose (OPTN) United States $0.298B 0.00
Xeris Pharmaceuticals (XERS) United States $0.291B 0.00
CASI Pharmaceuticals (CASI) United States $0.290B 0.00
ImmunoGen (IMGN) United States $0.280B 0.00
Concert Pharmaceuticals (CNCE) United States $0.271B 0.00
Dova Pharmaceuticals (DOVA) United States $0.264B 0.00
Aratana Therapeutics (PETX) United States $0.246B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.238B 0.00
Minerva Neurosciences (NERV) United States $0.231B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.225B 0.00
Lannett Co Inc (LCI) United States $0.222B 2.15
Recro Pharma (REPH) United States $0.215B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.200B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.196B 0.00
Aldeyra Therapeutics (ALDX) United States $0.195B 0.00
Opexa Therapeutics (ACER) United States $0.194B 0.00
Bio Blast Pharma (ENLV) Israel $0.188B 0.00
Galectin Therapeutics (GALT) United States $0.187B 0.00
Ocular Therapeutix (OCUL) United States $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
MEI Pharma (MEIP) United States $0.183B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.182B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.169B 0.00
Nature's Sunshine Products (NATR) United States $0.160B 51.88
Ardelyx (ARDX) United States $0.159B 0.00
Calithera Biosciences (CALA) United States $0.152B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
IMV INC (IMV) Canada $0.148B 0.00
AgeX Therapeutics (AGE) United States $0.148B 0.00
Jounce Therapeutics (JNCE) United States $0.147B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Majesco Entertainment (PTE) United States $0.138B 0.00
Neon Therapeutics (NTGN) United States $0.131B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Tyme Technologies (TYME) United States $0.114B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.103B 0.00
DURECT (DRRX) United States $0.102B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
Avenue Therapeutics (ATXI) United States $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.098B 70.00
Bellicum Pharmaceuticals (BLCM) United States $0.097B 0.00
China SXT Pharmaceuticals (SXTC) China $0.096B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Champions Oncology (CSBR) United States $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.092B 0.00
Cardiome Pharma (CORV) Canada $0.092B 0.00
MediWound (MDWD) Israel $0.088B 0.00
Natural Alternatives (NAII) United States $0.088B 8.80
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.081B 0.00
Capnia (SLNO) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.078B 0.00
Novan (NOVN) United States $0.072B 0.00
Melinta Therapeutics (MLNT) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Zafgen (ZFGN) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.046B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.045B 0.00
KemPharm (KMPH) United States $0.044B 0.00
Lipocine (LPCN) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.033B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.032B 0.00
PharmAthene (ALT) United States $0.030B 0.00
IsoRay (ISR) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
GTx (ONCT) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Pain Therapeutics (SAVA) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.64
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.81
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00